Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth.
Becker MA, Farzan T, Harrington SC, Krempski JW, Weroha SJ, Hou X, Kalli KR, Wong TW, Haluska P.
Becker MA, et al. Among authors: haluska p.
Mol Cancer Ther. 2013 Dec;12(12):2909-16. doi: 10.1158/1535-7163.MCT-13-0547. Epub 2013 Oct 15.
Mol Cancer Ther. 2013.
PMID: 24130056
Free PMC article.